The European Medicines Agency's (EMA) Information Management Division enables the Agency, its staff, members of its committees, working parties and advisory groups, and other stakeholders, to make efficient and effective use of information technology in order to achieve its organisational and policy objectives.

The European Medicines Agency (EMA) has three mission-critical task forces which support its human and veterinary medicines divisions, bringing together expertise to drive transformational change in high-priority areas of the Agency's work.

The European Medicines Agency (EMA) has been interacting with European healthcare professionals in various areas of its work since it was founded in 1995.

This page lists the Agency's annual budgets and accounts, as well as related documents. It also lists the Agency's financial regulation and implementing rules.

The European Medicines Agency (EMA) engages with a network of eligible patients and consumers organisations, ensuring that their needs and concerns are represented via direct contact with the Agency.

A range of services is available from the European Medicines Agency (EMA), Heads of Medicines Agencies (HMA) and European Commission to support innovative medicines and associated technology developments in the European Union (EU).

The European Medicines Agency (EMA) publishes opinions on the qualification of innovative development methods and letters of support for novel methodologies that have been shown to be promising in the context of research and development into pharmaceuticals.